Month: August 2017
-
Are Your Company’s Office Conditions Holding Your Business Back?
We take a look at ways you can sort out your office and boost your workforce.
-
Study Testing Repurposed Drugs with Resistant Bacteria
A university team is investigating two current drug compounds for their ability to take on a new task, fighting bacteria becoming resistant to antibiotics.
-
AstraZeneca, Biotech Partner on Messenger RNA Therapies
Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments.
-
Five Ways Science and Technology are Changing Transport
Another industry which is quickly developing with new technologies is transport. Here are 5 ways technology and science are changing the field of transportation.
-
Small Business Grant Funds Blood-Brain Barrier Model
A spin-off company from University of Washington is developing a chip device emulating the blood-brain barrier that prevents many drugs from treating neurological disorders.
-
Cryptography Technique Boosts Genomic Privacy
A team of geneticists and computer scientists developed a technique of analyzing disease-causing mutations in a human genome without revealing other genetic data.
-
Telemedicine Shown Feasible for Parkinson’s Care
Findings from a one-year clinical trial show individuals in the U.S. with Parkinson’s disease can receive quality care through telemedicine comparable to persons with the disorder receiving the usual care from neurologists alone.
-
Five Lessons Everyone In Business Needs To Learn
We came up with a list of business lessons you should make note of as early as possible and remember from now until the day you retire.
-
Tracking Algorithms Devised to ID Human Traffickers
Computer scientists developed techniques that help identify the people placing sexual service advertisements by tracing the bitcoin payments for those ads.
-
Trial Testing Engineered Virus as Cancer Treatment
A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers.